Pexa AB (PEXAB.ST) Research

Pexa AB specializes in developing and commercializing innovative technologies within the realm of respiratory medicine. The firm provides lung researchers with a straightforward, non-invasive technique to collect microscopic particles that serve as potential biomarkers for conditions affecting the small airways. Established in 2010 by Anna-Carin Olin, Pexa AB is based in Gothenburg, Sweden.

Market snapshot

Symbol
PEXAB.ST
Price
$0.25
Day change
-0.40%
Market cap
$10.5M
P/E ratio
-2.41x
52-week range
0.164-0.55
Sector
Healthcare
Industry
Medical - Specialties

Peer companies

  • Amniotics AB (publ) (AMNI.ST)
  • Bonzun AB (publ) (BONZUN.ST)
  • Cyxone AB (publ) (CYXO.ST)
  • Hemcheck Sweden AB (publ) (HEMC.ST)
  • Idogen AB (publ) (IDOGEN.ST)
  • Learning 2 Sleep L2S AB (publ) (L2S.ST)
  • Pharmiva AB (publ) (PHARM.ST)
  • Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST)

Open Pexa AB (PEXAB.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.